Related Experiment Video

Updated: Feb 4, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.1K

Periprocedural Considerations for Anticoagulated Atrial Fibrillation Patients

Angela Collins-Yoder, Rachel E Collins

    Journal of Perianesthesia Nursing : Official Journal of the American Society of Perianesthesia Nurses
    |September 25, 2018
    PubMed

    Insights

    Managing anticoagulants for atrial fibrillation patients undergoing procedures requires careful balancing of bleeding and clotting risks. This involves clinical reasoning, understanding guidelines, pharmacology, and risk assessment tools for safe patient care.

    Area of Science:

    • Cardiology
    • Anesthesiology
    • Pharmacology

    Background:

    • Atrial fibrillation patients on anticoagulants require careful management during procedures.
    • Balancing anticoagulation needs with bleeding risks is crucial for patient safety.

    Purpose of the Study:

    • To discuss current guidelines for anticoagulant use in atrial fibrillation.
    • To review relevant pharmacology and risk assessment tools for periprocedural care.
    • To provide resources for optimal practice in managing these patients.

    Main Methods:

    • Review of current guidelines for anticoagulant therapy in atrial fibrillation.
    • Discussion of anticoagulant pharmacology.
    • Exploration of standardized tools for thrombus and bleeding risk quantification.

    Main Results:

    • Highlights the importance of clinical reasoning and preparation.
    • Emphasizes the need for standardized tools to assess risks.
    • Identifies perianesthesia providers as key leaders in protocol development.

    Conclusions:

    • Periprocedural management of anticoagulated atrial fibrillation patients is critical.
    • Collaboration among stakeholders is essential for creating effective protocols.
    • Individualized care plans are necessary for optimal patient outcomes.

    Keywords:
    CHAD-VAS scoreHAS BLED scoreatrial fibrillationdirect acting oral anticoagulants (DOACs)perianesthesia risksthrombosis risk

    More Related Videos

    Robotic Ablation of Atrial Fibrillation11:21

    Robotic Ablation of Atrial Fibrillation

    Published on: May 29, 2015

    20.2K
    Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

    Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

    Published on: July 20, 2022

    2.2K

    Related Concept Videos

    Amyloid Fibrils03:03

    Amyloid Fibrils

    Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
    Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
    12.0K
    Amyloid Fibrils03:03

    Amyloid Fibrils

    6.4K
    Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

    Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

    Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
    Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
    2.4K
    Fibril-associated Collagen01:11

    Fibril-associated Collagen

    Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
    For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
    3.4K
    Design Consideration01:22

    Design Consideration

    Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
    The factor of safety is another key...
    580
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    1.9K